HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ulla Vogel Selected Research

Xenobiotics

1/202021st Century Tools for Nanotoxicology: Transcriptomic Biomarker Panel and Precision-Cut Lung Slice Organ Mimic System for the Assessment of Nanomaterial-Induced Lung Fibrosis.
1/2012Genetic variations in multiple myeloma I: effect on risk of multiple myeloma.
11/2009Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ulla Vogel Research Topics

Disease

54Inflammation (Inflammations)
11/2023 - 09/2002
38Neoplasms (Cancer)
02/2024 - 11/2003
30Pneumonia (Pneumonitis)
03/2024 - 03/2005
25Acute-Phase Reaction
03/2024 - 04/2009
22Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 07/2006
19Carcinogenesis
05/2023 - 08/2002
18Lung Neoplasms (Lung Cancer)
09/2023 - 11/2003
13Breast Neoplasms (Breast Cancer)
02/2024 - 04/2006
12Cardiovascular Diseases (Cardiovascular Disease)
09/2023 - 04/2009
12Multiple Myeloma
05/2023 - 03/2007
9Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2019 - 01/2011
7Ulcerative Colitis
01/2019 - 05/2010
7Carcinoma (Carcinomatosis)
11/2015 - 07/2006
6Fibrosis (Cirrhosis)
01/2021 - 11/2015
6Crohn Disease (Crohn's Disease)
01/2019 - 05/2010
6Adenoma (Adenomas)
11/2015 - 07/2006
5Atherosclerosis
01/2021 - 01/2012
4Genetic Risk Score
01/2020 - 01/2014
4Acute Coronary Syndrome
01/2013 - 06/2009
4Coronary Disease (Coronary Heart Disease)
01/2013 - 02/2009
4Aberrant Crypt Foci
10/2004 - 08/2002
3Body Weight (Weight, Body)
03/2023 - 03/2008
3Atherosclerotic Plaque (Atheroma)
01/2021 - 01/2013
3Necrosis
01/2017 - 01/2015
2Colitis
01/2023 - 11/2015
2Disease Progression
01/2022 - 09/2012
2Lung Diseases (Lung Disease)
01/2020 - 09/2016

Drug/Important Bio-Agent (IBA)

26Proteins (Proteins, Gene)FDA Link
05/2023 - 08/2006
25Messenger RNA (mRNA)IBA
01/2023 - 09/2002
17DNA (Deoxyribonucleic Acid)IBA
02/2020 - 07/2002
15Carbon Nanotubes (Carbon Nanotube)IBA
03/2024 - 11/2014
13SootIBA
01/2022 - 04/2009
12Biomarkers (Surrogate Marker)IBA
09/2023 - 06/2006
10Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
03/2019 - 02/2007
9EnzymesIBA
02/2024 - 04/2006
9Vehicle Emissions (Emissions, Vehicle)IBA
01/2021 - 11/2003
91-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA
07/2015 - 11/2003
8CytokinesIBA
01/2017 - 09/2002
7Serum Amyloid A Protein (Serum Amyloid A)IBA
01/2023 - 04/2009
7LipidsIBA
01/2021 - 02/2009
7Interleukin-10 (Interleukin 10)IBA
01/2018 - 05/2010
7CarcinogensIBA
07/2012 - 11/2003
6titanium dioxide (Titania)FDA Link
01/2020 - 08/2012
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019 - 03/2005
6Transcription Factors (Transcription Factor)IBA
01/2018 - 06/2009
5C-Reactive ProteinIBA
01/2023 - 04/2009
5hydroxide ionIBA
01/2020 - 01/2014
5Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2018 - 11/2009
5insulin receptor-related receptor (IRR)IBA
01/2012 - 04/2006
5Sucrose (Saccharose)IBA
10/2004 - 08/2002
4PPAR gammaIBA
12/2023 - 02/2007
4Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2023 - 02/2009
4MetalsIBA
01/2023 - 12/2018
4ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2023 - 01/2015
4LipopolysaccharidesIBA
10/2021 - 04/2009
4Toll-Like Receptors (Toll-Like Receptor)IBA
10/2021 - 08/2013
4Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2021 - 11/2014
4SmokeIBA
11/2017 - 11/2009
4NF-kappa B (NF-kB)IBA
04/2016 - 01/2006
4Thalidomide (Thalomid)FDA Link
09/2012 - 08/2010
4DNA AdductsIBA
01/2010 - 08/2002
4NucleotidesIBA
02/2008 - 07/2005
3IronIBA
03/2024 - 01/2015
3Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
12/2023 - 09/2010
3graphene oxideIBA
10/2021 - 01/2017
3CholesterolIBA
01/2021 - 03/2010
3Apolipoproteins E (ApoE)IBA
01/2021 - 01/2009
3Particulate MatterIBA
01/2021 - 11/2011
3XenobioticsIBA
01/2020 - 11/2009
3SteroidsIBA
03/2019 - 02/2007
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2019 - 04/2008
3CelluloseIBA
02/2019 - 04/2017
3Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
01/2018 - 11/2009
3Pattern Recognition ReceptorsIBA
01/2018 - 01/2015
3AntioxidantsIBA
09/2017 - 04/2006
3MicroRNAs (MicroRNA)IBA
02/2017 - 07/2011
3Heme (Haem)IBA
01/2015 - 03/2011
3ProstaglandinsIBA
01/2014 - 11/2009
3Bortezomib (Velcade)FDA Link
02/2012 - 08/2010
38-hydroxyguanineIBA
01/2012 - 08/2006
3quinolineIBA
10/2004 - 06/2003
2Estrogens (Estrogen)FDA Link
02/2024 - 09/2017
2TungstenIBA
09/2023 - 03/2023
2Immunoglobulins (Immunoglobulin)IBA
05/2023 - 05/2015
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
03/2023 - 01/2009
2OxidesIBA
01/2023 - 12/2018
2Adenosine Triphosphate (ATP)IBA
01/2023 - 11/2015
2Interleukin-8 (Interleukin 8)IBA
01/2022 - 08/2007
2ApolipoproteinsIBA
01/2021 - 01/2016
2Silicon Dioxide (Silica)FDA LinkGeneric
01/2021 - 11/2015
2Testosterone (Sustanon)FDA Link
10/2020 - 12/2019
2Immunoglobulin G (IgG)IBA
01/2020 - 05/2015
2Amyloid (Amyloid Fibrils)IBA
11/2019 - 01/2017
2Vitamin A (Retinol)FDA LinkGeneric
06/2019 - 03/2012
2Selenoprotein PIBA
01/2018 - 01/2013
2Interleukin-6 (Interleukin 6)IBA
11/2017 - 08/2007
2Blood Proteins (Serum Proteins)IBA
01/2017 - 12/2013
2Gonadal Steroid Hormones (Sex Hormones)IBA
04/2016 - 02/2012

Therapy/Procedure

3Therapeutics
01/2019 - 09/2009
3Drug Therapy (Chemotherapy)
01/2015 - 03/2007